Dr. Wang-Fischer earned her MD at Xiangya (Class-77) and PhD from Xiangya and Laval University, Quebec, Canada in 1996. Following clinical fellowship training in cardiovascular and metabolic diseases at Xiangya, where she became an attending physician, she completed PhD
and postdoctoral fellowship training at the School of Medicine, Laval University and Boston University. She joined the Howard
Hughes Medical Institute at Yale University in 2000.

In 2002, Dr. Wang-Fischer joined the team of neurological
disorders at Johnson & Johnson. She led projects based on
different animal models to discover new drugs for treatment of stroke and neurological diseases.

In 2006, Dr. Wang-Fischer joined Palatin Technologies and took in charge of projects on nasal and cerebral drug delivery. She developed a novel technique to quickly assess nasal tolerance.

She has joined Chromocell Co., since 2010 and led project using animal models to discover new drugs for neurological diseases.

Dr. Wang-Fischer has published more than 40 scientific papers in prestigious medical journals. Her current interests include neurological, cardiovascular, metabolic and inflammatory diseases, mainly concerned with physiology and pharmacology in vivo.

The book is for sale at Amazon.com. You can find the detailed book information via the link: http://www.amazon.com/Manual-Stroke-Models-Yanlin-Wang-Fischer/dp/084939578X/ref=sr_1_2?ie=UTF8&qid=1335284510&sr=8-2.

For more information, please contact the author at yanlin2@hotmail.com.

Congratulations, Dr. Yanlin Wang!